Elite in Squamous Cell Lung Carcinoma

Dr. Prasad S. Adusumilli

Thoracic Surgery
Mskcc Surgery Group
1275 York Ave, 
New York, NY 
Offers Telehealth
Elite in Squamous Cell Lung Carcinoma
Mskcc Surgery Group
1275 York Ave, 
New York, NY 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Prasad Adusumilli is a Thoracic Surgeon in New York, New York. Dr. Adusumilli is rated as an Elite provider by MediFind in the treatment of Squamous Cell Lung Carcinoma. His top areas of expertise are Lung Adenocarcinoma, Mesothelioma, Lung Cancer, Advanced Bronchoscopy, and Endoscopy.

His clinical research consists of co-authoring 291 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 4 articles in the study of Squamous Cell Lung Carcinoma.

Specialties
Thoracic Surgery
Licenses
Thoracic Surgery (Cardiothoracic Vascular Surgery) in NY
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Cigna
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO

Locations

MSKCC SURGERY GROUP
1275 York Ave, New York, NY 10065

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Phase I/II Clinical Trial of Malignant Pleural Disease Treated With Autologous T Cells Genetically Engineered to Target the Cancer-Cell Surface Antigen Mesothelin
A Phase I/II Clinical Trial of Malignant Pleural Disease Treated With Autologous T Cells Genetically Engineered to Target the Cancer-Cell Surface Antigen Mesothelin
Enrollment Status: Active_not_recruiting
Publish Date: October 08, 2025
Intervention Type: Drug, Genetic
Study Drug: Cyclophosphamide
Study Phase: Phase 1/Phase 2
A Phase I Clinical Trial to Evaluate the Safety and Tolerability of Mesothelin-Specific Chimeric Antigen Receptor-Positive T Cells in Patients With Metastatic Mesothelin-Expressing Breast Cancer
A Phase I Clinical Trial to Evaluate the Safety and Tolerability of Mesothelin-Specific Chimeric Antigen Receptor-Positive T Cells in Patients With Metastatic Mesothelin-Expressing Breast Cancer
Enrollment Status: Active_not_recruiting
Publish Date: July 17, 2025
Intervention Type: Drug, Biological
Study Drugs: Cyclophosphamide, Mesothelin-targeted T cells, AP1903
Study Phase: Phase 1
A Prospective Clinical Trial to Evaluate Mesothelin as a Biomarker for the Clinical Management of Esophageal Adenocarcinoma (EAC)
A Prospective Clinical Trial to Evaluate Mesothelin as a Biomarker for the Clinical Management of Esophageal Adenocarcinoma (EAC)
Enrollment Status: Completed
Publish Date: October 28, 2024
Intervention Type: Other
View 2 Less Clinical Trials

291 Total Publications

Intraperitoneal CAR T-cell therapy for peritoneal carcinomatosis from gastroesophageal cancer: preclinical investigations to a phase I clinical trial (NCT06623396).
Intraperitoneal CAR T-cell therapy for peritoneal carcinomatosis from gastroesophageal cancer: preclinical investigations to a phase I clinical trial (NCT06623396).
Journal: Journal for immunotherapy of cancer
Published: August 27, 2025
Similar Doctors
Valerie W. Rusch
Elite in Squamous Cell Lung Carcinoma
Dr. Valerie W. Rusch
Thoracic Surgery
Elite in Squamous Cell Lung Carcinoma
Dr. Valerie W. Rusch
Thoracic Surgery
1275 York Ave, 
New York, NY 
 (0.1 miles away)
212-639-2000
Languages Spoken:
English
See accepted insurances

Valerie Rusch is a Thoracic Surgeon in New York, New York. Dr. Rusch is rated as an Elite provider by MediFind in the treatment of Squamous Cell Lung Carcinoma. Her top areas of expertise are Mesothelioma, Lung Cancer, Lung Adenocarcinoma, Tissue Biopsy, and Thymectomy.

Bernard J. Park
Distinguished in Squamous Cell Lung Carcinoma
Dr. Bernard J. Park
Thoracic Surgery
Distinguished in Squamous Cell Lung Carcinoma
Dr. Bernard J. Park
Thoracic Surgery

Mskcc Surgery Group

1275 York Ave, 
New York, NY 
 (0.1 miles away)
212-639-2000
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Bernard Park is a Thoracic Surgeon in New York, New York. Dr. Park is rated as an Elite provider by MediFind in the treatment of Squamous Cell Lung Carcinoma. His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Lung Adenocarcinoma, Advanced Bronchoscopy, and Endoscopy. Dr. Park is currently accepting new patients.

Raja M. Flores
Distinguished in Squamous Cell Lung Carcinoma
Dr. Raja M. Flores
Thoracic Surgery
Distinguished in Squamous Cell Lung Carcinoma
Dr. Raja M. Flores
Thoracic Surgery

Icahn School Of Medicine At Mount Sinai

1190 5th Ave, Gp2w, 
New York, NY 
 (1.8 miles away)
212-241-5646
Languages Spoken:
English
See accepted insurances

Raja Flores is a Thoracic Surgeon in New York, New York. Dr. Flores is rated as an Elite provider by MediFind in the treatment of Squamous Cell Lung Carcinoma. His top areas of expertise are Lung Cancer, Mesothelioma, Non-Small Cell Lung Cancer (NSCLC), Endoscopy, and Thymectomy.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Adusumilli's expertise for a condition
ConditionClose
View All 7 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile